Ads
related to: Eli Lilly Stock Price and Research Reports- Press Releases
Find Press Releases
and News for Lilly.
- Lilly Recognitions
Leaders in D&I, R&D, and
Social Impact & Employee Benefits
- About Lilly
Find How Lilly's Purpose Has Never
Been More Important.
- Our Impact
Learn About How We Responsibly
Grow Our Business.
- Press Releases
Search results
Roche (RHHBY) Posts Encouraging Phase I Obesity Drug Data
Zacks· 5 days agoManagement noted that the side effects of the drug were similar to the currently marketed...
4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly - Altimmune (NASDAQ:ALT), Amgen...
Benzinga· 4 days agoIt was only after a couple of years that the market gained a second entrant – Eli Lilly's LLY...
3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance
Zacks· 5 days agoAmid these headwinds, three drugmakers — Eli Lilly and Company (LLY Quick QuoteLLY - Free Report) , Novo Nordisk (NVO Quick QuoteNVO ...
Hims & Hers Health says it will offer compounded GLP-1 drugs, despite FDA warnings
Market Watch· 22 hours agojumped more than 30% Monday morning after the health and wellness platform said it would offer...
Markets News, May 20, 2024: Tech Lifts Nasdaq to Record; JPMorgan Drags Dow Below 40K
Investopedia· 18 hours agoU.S. stocks were mixed on Monday, with tech stocks climbing and the Dow hovering around 40,000, a...
Roche (RHHBY) Posts Encouraging Phase I Obesity Drug Data
Zacks via Yahoo Finance· 5 days agoData from the study shows that nearly half of the patients who received Roche's (RHHBY)...
Should You Hold Viking Therapeutics (VKTX) in Your Portfolio?
Zacks via Yahoo Finance· 6 days agoViking Therapeutics' (VKTX) lead candidate for obesity, VK2735, is expected to have tremendous...
3 Stocks Benefitting From the Market's Unstoppable Surge
InvestorPlace· 4 days agoMajor indices continue to climb Despite ongoing concerns over sticky inflation, high interest rates...
Why Jamie Dimon’s Buyback Bombshell Is a Warning for Stocks, and 5 Other Things to Know Before the...
Barrons.com· 3 hours agoNorwegian Cruise Line soars on profit guidance, Red Lobster bankruptcy blamed on shrimp promotion,...
Hims & Hers Health says it will offer compounded GLP-1 drugs, despite FDA warnings
Morningstar· 14 hours agoHims & Hers Health Inc.'s stock (HIMS) jumped nearly 30% on Monday after the health and wellness platform said it would offer compounded GLP-1 drugs - products that the Food ...
Ad
related to: Eli Lilly Stock Price and Research Reports